Abstract
Background
Some patients with typical (heartburn/regurgitation) symptoms of gastroesophageal reflux disease (GERD) are refractory to proton pump inhibitor (PPI) therapy. Impedance-pH monitoring can identify PPI-refractory patients who could benefit from laparoscopic fundoplication, but outcome data are scarce. We aimed to assess whether PPI-refractory GERD as diagnosed by impedance-pH monitoring can be cured by laparoscopic fundoplication.
Methods
Forty-four consecutive GERD patients with heartburn/regurgitation refractory to high-dose PPI therapy entered a 3-year outcome assessment following robot-assisted laparoscopic fundoplication. Preoperative on-PPI impedance-pH diagnostic criteria consisted of positive symptom association probability (SAP)/symptom index (SI), and/or abnormal percentage esophageal acid exposure time (%EAET), and/or abnormal number of total refluxes. GERD cure was defined by 3-year postoperative off-PPI normal impedance-pH findings with persistent symptom remission.
Results
Preoperatively, 24 of 38 (63 %) patients who completed the outcome assessment had a positive SAP/SI, 20 of 38 (53 %) for weakly acidic refluxes; 3 of 38 (8 %) patients had an abnormal %EAET, 11 of 38 (29 %) an abnormal number of total refluxes only. Postoperatively, heartburn/regurgitation recurred in 3 patients; abnormal impedance-pH findings were found in two of them, and they responded to PPI therapy. GERD cure was achieved in 34 of 38 (89 %) patients, 11 of 11 with an abnormal number of total refluxes as the only preoperative abnormal impedance-pH finding. Postoperatively, there was a significant decrease of the %EAET (1 vs. 0.1 %, P = 0.002) and of the number of total refluxes (68 vs. 8, P = 0.001), with the latter finding mainly due to a decrease in the number of weakly acidic refluxes.
Conclusions
Normal reflux parameters and persistent symptom remission at 3-year follow-up can be achieved with laparoscopic fundoplication in the majority of patients with PPI-refractory GERD as diagnosed by impedance-pH monitoring. On-PPI impedance-pH diagnostic criteria should include SAP/SI positivity, an abnormal %EAET, and an abnormal number of total refluxes. Weakly acidic refluxes have a major role in the pathogenesis of PPI-refractory GERD.
Similar content being viewed by others
References
Kahrilas PJ, Shaheen NJ, Vaezi MF (2008) American Gastroenterological Association Institute technical review on the management of gastroesophageal reflux disease. Gastroenterology 135:1392–1413
Sifrim D, Zerbib F (2012) Diagnosis and management of patients with reflux symptoms refractory to proton pump inhibitors. Gut 61:1340–1354
Dallemagne B, Weerts J, Markiewicz S, Dewandre JM, Wahlen C, Monami B, Jehaes C (2006) Clinical results of laparoscopic fundoplication at ten years after surgery. Surg Endosc 20:159–165
Stefanidis D, Hope WW, Kohn GP, Reardon PR, Richardson DS, Fanelli RD; The SAGES Guidelines Committee (2010) Guidelines for surgical treatment of gastroesophageal reflux disease. Surg Endosc 24:2647–2669
Tutuian R, Castell DO (2006) Review article: complete gastro-oesophageal reflux monitoring—combined pH and impedance. Aliment Pharmacol Ther 24(Suppl 2):27–37
Pandolfino JE, Vela MF (2009) Esophageal reflux monitoring. Gastrointest Endosc 69:917–930
Frazzoni M, Conigliaro R, Melotti G (2011) Reflux parameters as modified by laparoscopic fundoplication in 40 patients with heartburn/regurgitation persisting despite PPI therapy. A study using impedance-pH monitoring. Dig Dis Sci 56:1099–1106
Frazzoni M, Conigliaro R, Colli G, Melotti G (2012) Conventional versus robot-assisted laparoscopic Nissen fundoplication. A comparison of postoperative acid reflux parameters. Surg Endosc 26:1675–1681
Lundell LR, Dent J, Bennett JR, Blum AL, Armstrong D, Galmiche JP, Johnson F, Hongo M, Richter JE, Spechler SJ, Tytgat GNJ, Wallin L (1999) Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut 45:172–180
Frazzoni M, Conigliaro R, Mirante VG, Melotti G (2012) The added value of quantitative analysis of on-therapy impedance-pH parameters in distinguishing refractory non-erosive reflux disease from functional heartburn. Neurogastroenterol Motil 24:141-e87
Frazzoni M, Grisendi A, Lanzani A, Melotti G, De Micheli E (2002) Laparoscopic fundoplication versus lansoprazole for gastro-oesophageal reflux disease—a pH-metric comparison. Dig Liver Dis 34:99–104
Frazzoni M, Savarino E, Manno M, Melotti G, Mirante VG, Mussetto A, Bertani H, Manta R, Conigliaro R (2009) Reflux patterns in patients with short segment Barrett’s oesophagus: a study using impedance-pH monitoring off and on proton pump inhibitor therapy. Aliment Pharmacol Ther 30:508–515
Sifrim D, Castell D, Dent J, Kahrilas PJ (2004) Gastro-oesophageal reflux monitoring: review and consensus report on detection and definitions of acid, non-acid, and gas reflux. Gut 53:1024–1031
Zerbib F, Roman S, Ropert A, Bruley des Varannes S, Pouderoux P, Chaput U, Mion F, Verin E, Galmiche JP, Sifrim D (2006) Esophageal pH-impedance monitoring and symptom analysis in GERD: a study in patients off and on therapy. Am J Gastroenterol 101:1956–1963
Agrawal A, Roberts J, Sharma N, Tutuian R, Vela M, Castell DO (2009) Symptoms with acid and nonacid reflux may be produced by different mechanisms. Dis Esophagus 22:467–470
Fass R (2012) Therapeutic options for refractory gastroesophageal reflux disease. J Gastroenterol Hepatol 27(Suppl 3):3–7
Frazzoni M, Conigliaro R, Manta R, Melotti G (2011) Reflux parameters as modified by EsophyX or laparoscopic fundoplication in refractory GERD. Aliment Pharmacol Ther 34:67–75
Witteman B, Strijkers R, de Vries E, Toemen L, Conchillo JM, Hameetemn W, Dagnelie PC, Koek GH, Bouvy ND (2012) Transoral incisionless fundoplication for treatment of gastroesophageal reflux disease in clinical practice. Surg Endosc 26:3307–3315
Galmiche JP, Hatlebakk J, Attwood S, Ell C, Fiocca R, Eklund S, Langstrom G, Lind T, Lundell L (2011) Laparoscopic antireflux surgery vs esomeprazole treatment for chronic GERD—the LOTUS randomized clinical trial. JAMA 305:1969–1977
Mainie I, Tutuian R, Agrawal A, Adams D, Castell DO (2006) Combined multichannel intraluminal impedance-pH monitoring to select patients with persistent gastro-oesophageal reflux for laparoscopic Nissen fundoplication. Br J Surg 93:1483–1487
Broeders JA, Rijnhart-de Jong HG, Draaisma WA, Bredenoord AJ, Smout AJ, Gooszen HG (2009) Ten-year outcome of laparoscopic and conventional Nissen fundoplication: randomized clinical trial. Ann Surg 250:698–706
Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R; Global Consensus Group (2006) The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol 101:1900–1920
Bytzer P (2004) Assessment of reflux symptom severity: methodological options and their attributes. Gut 53(Suppl 4):iv28–iv34
Slaughter JC, Goutte M, Rymer JA, Oranu AC, Schneider JA, Garrett CG, Hagaman D, Vaezi MF (2011) Caution about overinterpretation of symptom indexes in reflux monitoring for refractory gastroesophageal reflux disease. Clin Gastroenterol Hepatol 9:868–874
Pritchett JM, Aslam M, Slaughter JC, Ness RM, Garrett CG, Vaezi MF (2009) Efficacy of esophageal impedance/pH monitoring in patients with refractory gastroesophageal reflux disease, on and off therapy. Clin Gastroenterol Hepatol 7:743–748
Frazzoni M, Conigliaro R, Melotti G (2011) Weakly acidic refluxes have a major role in the pathogenesis of proton pump inhibitor–resistant reflux oesophagitis. Aliment Pharmacol Ther 33:601–606
Krishnan K, Pandolfino J, Kahrilas P, Keffer L, Boris L, Komandur S (2012) Increased risk for persistent intestinal metaplasia in patients with Barrett’s esophagus and uncontrolled reflux exposure before radiofrequency ablation. Gastroenterology 143:576–581
Bredenoord AJ, Draaisma WA, Weusten BLAM, Gooszen HG, Smout AJPM (2008) Mechanisms of acid, weakly acidic and gas reflux after anti-reflux surgery. Gut 57:161–166
Herbella F, Vicentine F, Del Grande J, Patti MG (2011) Postprandial proximal gastric acid pocket in patients after laparoscopic Nissen fundoplication. Surg Endosc 25:3198–3201
Benson K, Hartz A (2000) A comparison of observational studies and randomized, controlled trials. N Engl J Med 342:1878–1886
Concato J, Shah N, Horwitz RI (2000) Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med 342:1887–1892
Scarpignato C (2012) Poor effectiveness of proton pump inhibitors in non-erosive reflux disease: the truth in the end! Neurogastroenterol Motil 24:697–704
Disclosures
Marzio Frazzoni, Micaela Piccoli, Rita Conigliaro, Raffaele Manta, Leonardo Frazzoni, and Gianluigi Melotti have no conflicts of interest or financial ties to disclose.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Frazzoni, M., Piccoli, M., Conigliaro, R. et al. Refractory gastroesophageal reflux disease as diagnosed by impedance-pH monitoring can be cured by laparoscopic fundoplication. Surg Endosc 27, 2940–2946 (2013). https://doi.org/10.1007/s00464-013-2861-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00464-013-2861-3